Search

Your search keyword '"Rossi, Davide"' showing total 999 results

Search Constraints

Start Over You searched for: Author "Rossi, Davide" Remove constraint Author: "Rossi, Davide" Journal blood Remove constraint Journal: blood
999 results on '"Rossi, Davide"'

Search Results

1. Genetic and phenotypic attributes of splenic marginal zone lymphoma

2. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

3. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1

5. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

7. The genetics of nodal marginal zone lymphoma

9. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

11. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

13. Genomic profiling for clinical decision making in lymphoid neoplasms

15. Clonal Evolution of Chronic Lymphocytic Leukemia with Bimodal CD49d Expression Reveals CD49d Plasticity

17. The CXCR4dim/CD5bright Proliferative Fraction Reappears in Relapsed CLL Under Ibrutinib, Enriched in BTK Mutations

18. A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110

19. Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas

20. Real-World Effectiveness and Safety of Venetoclax in Combination with Obinutuzumab in Treatment-Naive CLL Patients - Data from the Observational Study Verve

21. MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials & Implications for Clinical Trial Design

22. Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling

24. Molecular Clustering on Ctdna May Improve Prognostic Stratification of DLBCL Patients

27. Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

28. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

29. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

30. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

31. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

32. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

33. Distinct Modes of Ongoing Antigen Interactions Shape Intraclonal Dynamics in Splenic Marginal Zone Lymphoma

34. Different Prognostic Impact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated Chronic Lymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, the European Research Initiative on CLL, in Harmony

35. Safety and Effectiveness of Venetoclax/Rituximab in Bcri-Naïve and Bcri-Exposed Patients with Relapsed/Refractory CLL Under Real-Life Conditions - Data from the Observational Verve Study

36. Efficacy of Front-Line Ibrutinib Versus Fludarabine, Cyclophosphamide and Rituximab (FCR) in Patients with CLL. a Multicenter "Real-World" Study

37. Circulating Tumor DNA Integrated with Interim [18F]FDG PET Is Highly Effective in Predicting Outcome of Relapsed/Refractory Classical Hodgkin Lymphoma Treated with the Begev Regimen

38. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

39. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

40. First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial

41. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia

44. Evaluation of the Different Stratification Models for POD24 Prediction in Patients with Follicular Lymphoma

45. Mutations of the Exportin 1 (XPO1) Gene Predict Shorter Time to First Treatment in 1092 Early Stage Chronic Lymphocytic Leukemia Patients. Α Training/Validation Study

46. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

47. CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

48. Clinical Impact of Clonal and Subclonal TP53 Mutations and Deletions in Chronic Lymphocytic Leukemia: An Italian Multicenter Experience

49. External Validation of a Novel Risk Model (BALL Score) in Real-World Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib. a Campus CLL Study

50. Secreted Factors Determine Resistance to Idelalisib in Marginal Zone Lymphoma Models of Resistance

Catalog

Books, media, physical & digital resources